Literature DB >> 14287320

PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION.

N PETERS, C N HALES.   

Abstract

Keywords:  BLOOD; BLOOD SUGAR; GLUCOSE TOLERANCE TEST; INSULIN; METABOLISM; MYOCARDIAL INFARCT

Mesh:

Substances:

Year:  1965        PMID: 14287320     DOI: 10.1016/s0140-6736(65)91962-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Diabetes and atherosclerosis. Metabolic links.

Authors:  G Steiner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Arterial lipid metabolism in relation, to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes.

Authors:  R W Stout; K D Buchanan; J Vallance-Owen
Journal:  Diabetologia       Date:  1972-12       Impact factor: 10.122

3.  Glucose tolerance and insulin secretion in patients with chronic duodenal ulcer.

Authors:  C S Humphrey; J R Dykes; D Johnston
Journal:  Br Med J       Date:  1972-11-18

4.  Hormonal and metabolic disturbances during acute and subacute myocardial infarction in man.

Authors:  G Boden
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

5.  Fasting serum insulin levels in childhood.

Authors:  D B Grant
Journal:  Arch Dis Child       Date:  1967-08       Impact factor: 3.791

6.  The effect of insulin on the incorporation of sodium (1- 14 C)-acetate into the lipids of the rat aorta.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1971-10       Impact factor: 10.122

7.  Thrombosis in coronary heart disease.

Authors:  L McDonald
Journal:  Br Heart J       Date:  1968-03

8.  Development of vascular lesions in insulin-treated animals fed a normal diet.

Authors:  R W Stout
Journal:  Br Med J       Date:  1970-09-19

Review 9.  Is insulin atherogenic?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 10.  Angiotensin and insulin resistance: conspiracy theory.

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.